Henry Fuchs
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Henry Fuchs
The proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $8,127,856 for Henry Fuchs in fiscal 2024, including a base salary of $838,731. Disclosed compensation is on record for 8 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Biomarin Pharmaceutical Inc (BMRN)
Proxy statement
Start not stated–2025-03-03
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Biomarin Pharmaceutical Inc (BMRN) | Former President, Worldwide Research & Development | $838,731 | $8,127,856 |
| 2023 | Biomarin Pharmaceutical Inc (BMRN) | Former President, Worldwide Research & Development | $818,269 | $9,660,818 |
| 2022 | Biomarin Pharmaceutical Inc (BMRN) | Former President, Worldwide Research & Development | $782,308 | $8,704,454 |
| 2021 | Biomarin Pharmaceutical Inc (BMRN) | President, Worldwide R&D | $750,000 | $6,929,366 |
| 2020 | Biomarin Pharmaceutical Inc (BMRN) | President, Worldwide R&D | $769,231 | $7,456,575 |
| 2019 | Biomarin Pharmaceutical Inc (BMRN) | President, Worldwide R&D | $695,192 | $7,017,499 |
| 2018 | Biomarin Pharmaceutical Inc (BMRN) | President, Worldwide R&D | $668,269 | $5,777,729 |
| 2017 | Biomarin Pharmaceutical Inc (BMRN) | President, Worldwide R&D | $637,231 | $7,045,424 |
Recent activity
No call appearances or filed executive changes recorded yet.